<?xml version="1.0" encoding="UTF-8"?>
<p>In recent years, remdesivir has been tested extensively for its efficacy, especially during the West African Ebola virus epidemic. It has also shown promising results during the 2018 Kivu Ebola epidemic. Starting March 17, 2020, remdesivir has been provisionally approved in Czech Republic for use in COVID-19 patients.</p>
